Quiescence improves Candida albicans survival of fungicidal drug exposure
Ozan Berk ImiriD, Marina E. DruseikisiD, Ying XieiD, Yujia JiiD, Liam J. HoltiD, Judith G. BermaniD, David GreshamiD
Abstract
Quiescence, defined as the reversible exit from mitotic division and proliferative growth, is the predominant state of all microbes. Despite its prevalence, the properties and consequences of quiescence in Candida albicans, an opportunistic fungal pathogen, remain largely unexplored. In this study, we characterized the morphological, molecular, and biophysical properties of quiescent C. albicans cells and assessed the effects of quiescence on antifungal drug efficacy. Quiescent cells that were induced via carbon starvation in rich and minimal media underwent distinct morphological changes upon entry into quiescence; this included an increase in cell buoyant density, altered fluidity of the cytoplasm and nucleus, and remodeling of mitochondria. Most C. albicans cells arrested in an unbudded G1/G0 state, although a significant fraction of cells had budded morphologies and 4N DNA content, indicating that they arrested at other cell cycle phases. Both budded and unbudded quiescent cells efficiently re-entered the cell cycle upon nutrient replenishment, with time-to-quiescence exit varying depending on the total nutritional quality of the medium. Quiescence was associated with large-scale gene expression remodeling, including downregulation of ribosomal biogenesis genes and upregulation of autophagy and stress response pathways. Notably, a greater proportion of quiescent cells than proliferative cells survived exposure to the commonly used antifungal drugs micafungin, caspofungin, and amphotericin B in genetically diverse strains. Thus, quiescence is a distinct cellular state with important implications for antifungal drug efficacy in C. albicans. Author SummaryWe show that Candida albicans, a common fungal pathogen, can enter a reversible, non-dividing state when starved of carbon. Starved cells become smaller and denser, reorganize their mitochondria, change how densely packed the inside of the cell and its nucleus are, and switch on stress-protection and internal recycling programs while reducing protein synthesis activity. Most cells have ceased to actively divide, but many retained budded shapes and could restart growth when nutrients returned; the timing of recovery depended on the nutritional environment in which quiescence was initiated. Critically, quiescent cells from laboratory and clinical strains exhibited greater survival than proliferative cells when exposed to widely used fungicidal drugs including micafungin, caspofungin, and amphotericin B. These findings indicate that quiescence is an active, adaptive physiological state that helps Candida albicans survive hostile environmental conditions such as temperature stress and drug exposure. Accounting for the metabolic state of fungal cells in diagnostics and drug development may improve treatment outcomes.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Candida albicans exhibits heterogeneous and adaptive cytoprotective responses to anti-fungal compounds
V. Dumeaux, S. Massahi, … M. T. Hallett·bioRxiv·Jul 20, 2022
- Candida albicans biofilms are generally devoid of persister cells
I. Denega, C. D'Enfert, S. Bachellier-Bassi·bioRxiv·Sep 20, 2018
- Candida albicans exhibits distinct cytoprotective responses to anti-fungal drugs that facilitate the evolution of drug resistance
Van Bettauer, Samira Massahi, … Michael T. Hallett·bioRxiv·Jan 21, 2020
- Thirty years of fluconazole therapy selects an azole-resistant Candida albicans isolate with a pre-adapted physiological, metabolic and structural state
Claudia Marcela Parra‐Giraldo, Julio Jesús Estrada‐Valbuena, … Lucía Monteoliva·bioRxiv·Sep 21, 2026
- Live-cell imaging of pathogenic fungal hyphae reveal dynamic cellular responses to clinical antifungals
Darren D. Thomson, Robert Davies Inman, … Elaine Bignell·Journal of MicroscopyPeer-reviewed·Dec 18, 2025
- Antifungal effects of alantolactone on Candida albicans: an in vitro study